Current research is focused on ion channels medicating calcium translocation sodium influx, potassium efflux and nicotinic receptor-mediated sodium and calcium influx. Capacitative calcium influx, IP3-mediated release of intracellular calcium, and calcium ATPases are under study in leukemic HL-60 cells using a variety of agents including loperamide, trifluperazine, N-methyldihydropyridines, and imidazoles, such as SKF 9365, miconazole and clotrimazole, all of which affect capacitative calcium influx. Agents such as the steroidal maleimide U73122 that inhibits phospholipase A2, aminoethyl diphenyl borane and xestospongin that inhibit IP3-receptors are under study, as are the effects of caffeine, and analogs, which can activate influx of calcium, elicit release of calcium through ryanodine-sensitive channels, and inhibit IP3-dependent release of calcium. The mechanism, whereby loperamide selectivity enhances elevations of calcium maintained through capacitative calcium influx, remains undefined. A variety of lipophilic drugs, in addition to inhibition of calcium influx, can trigger calcium-release from endoplasmic reticulum through activation of phospholipase C. As yet, no selective inhibitor of capacitative calcium influx has been defined. A wide range of nicotinic agonists and noncompetitive blockers have been studied in cultured cells expressing central, ganglionic or neuromuscular nicotinic receptors in an attempt to define structural elements that will lead to selective nicotinic agents, certain of which might retain the analgetic properties of the frog skin alkaloid, epibatidine, while lacking the toxic effects of that alkaloid. Selective antagonists, non-competitive blockers and allosteric activators also are being sought. Effects of pumiliotoxins on activation and/or inhibition of sodium channels in neuroblastoma cells have been initiated in efforts to develop cardiotonic analogs with therapeutic potential for cardiac failure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK031102-30
Application #
6508986
Study Section
(LBC)
Project Start
Project End
Budget Start
Budget End
Support Year
30
Fiscal Year
2001
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Hayallah, Alaa M; Sandoval-Ramirez, Jesus; Reith, Ulrike et al. (2002) 1,8-disubstituted xanthine derivatives: synthesis of potent A2B-selective adenosine receptor antagonists. J Med Chem 45:1500-10
Flowers, Andrew; Onwueme, Kenolisa; Creveling, Cyrus R et al. (2002) Reserpine: interactions with batrachotoxin and brevetoxin sites on voltage-dependent sodium channels. Cell Mol Neurobiol 22:1-12
Jiang, X; Lim, L Y; Daly, J W et al. (2000) Structure-activity relationships for G2 checkpoint inhibition by caffeine analogs. Int J Oncol 16:971-8
Daly, J W (2000) Alkylxanthines as research tools. J Auton Nerv Syst 81:44-52
Daly, J W; Garraffo, H M; Spande, T F et al. (2000) Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics. Nat Prod Rep 17:131-5
Daly, J W; Harper, J (2000) Loperamide: novel effects on capacitative calcium influx. Cell Mol Life Sci 57:149-57